Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial (ACTCOVID19)
Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial
Sponsor: Bayer
Listed as NCT04324463, this PHASE3 trial focuses on Coronavirus and Severe Acute Respiratory Syndrome and remains completed. Sponsored by Bayer, it has been updated 19 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
19 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Feb 2024 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Dec 2023 — Feb 2024 [monthly]
Active Not Recruiting PHASE3
▶ Show 14 earlier versions
-
Sep 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE3
-
Jun 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE3
-
Feb 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE3
-
Nov 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE3
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting PHASE3
-
Apr 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Feb 2022 — Apr 2022 [monthly]
Recruiting PHASE3
-
Jun 2021 — Feb 2022 [monthly]
Recruiting PHASE3
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE3
-
Jul 2020 — Oct 2020 [monthly]
Recruiting PHASE3
-
May 2020 — Jul 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Apr 2020 — May 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
- Population Health Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Al Fayyum, Egypt , Ambato, Ecuador , Bangalore, India , Barnaul, Russia , Barranquilla, Colombia , Bento Gonçalves, Brazil , Bhadrapur, Nepal , Bharatpur-10, Nepal , Biratnagar, Nepal , Bucaramanga, Colombia and 42 more locations